Restasis (cyclosporine ophthalmic emulsion) is a prescription drug that’s used to treat dry eye syndrome. The drug comes as an emulsion (oily liquid). You usually apply 1 drop into each affected eye ...

The Food and Drug Administration (FDA) has approved Restasis for treating chronic dry eye in adults and children ages 16 years and older. It’s available in single-use vials and a multiuse bottle.

You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...

Yes, people with Medicare Part D who use Restasis may be eligible for a patient assistance program called myAbbVie Assist. This article discusses whether Medicare covers Restasis, Medicare ...

(RTTNews) - Viatris Inc. (VTRS) said that its subsidiary, Mylan Pharmaceuticals Inc., has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for ...

DUBLIN, Jan. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that its subsidiary, Watson Laboratories, Inc., has submitted an Abbreviated New Drug Application (ANDA) with the U.S.

Why are Americans, both as patients and taxpayers, paying billions of dollars for a drug whose efficacy is so questionable that it's not approved in the European Union, Australia or New Zealand?